（文章来源：证券日报） 证券日报网讯 1月29日，汉邦科技发布公告称，由于天健会计师事务所内部工作调整，现委派杨天将接 替吴慧作为签字注册会计师。变更后的签字注册会计师为朱俊峰和杨天将。 ...

江苏汉邦科技股份有限公司 证券代码：688755 证券简称：汉邦科技 公告编号：2026-003 关于变更签字注册会计师的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 经江苏汉邦科技股份有限公司（以下简称"公司"）第一届董事会第十八 次会议和公司2024年年度股东大会审议通过，同意聘任天健会计师事务所（特 殊普通合伙）（以下简称"天健会计师事务所"）担任公司2025年度财务报表 和内部控制审计机构。 近日，公司收到天健会计师事务所出具的《关于变更签字注册会计师的函》， 现将具体情况公告如下： 一、本次变更签字注册会计师的基本情况 天健会计师事务所作为公司2025年度财务报表和2025年末财务报告内部控 制审计机构，原委派吴慧和朱俊峰作为公司2025年度财务报表审计报告和2025 年末财务报告内部控制审计报告的签字注册会计师。由于天健会计师事务所内部 工作调整，现委派杨天将接替吴慧作为签字注册会计师。变更后的签字注册会计 师为朱俊峰和杨天将。 二、本次变更签字注册会计师的基本信息 1.人员信息 签字注册会计师：杨天将，2 ...

Core Insights - The article highlights that Jiangsu Province led the nation in IPOs in 2025, with 46 companies listed, accounting for 15% of the national total [5][6][11] - The report emphasizes the long-term development of Jiangsu's capital efficiency and industrial ecosystem, which has resulted in a significant increase in IPO activity [6][19] Summary by Sections IPO Data Overview - In 2025, a total of 294 IPOs occurred nationwide, with Jiangsu Province achieving the highest number [5] - The total IPO amount for Jiangsu reached 40.858 billion yuan, more than doubling from the previous year [6] Industry Distribution - The majority of IPOs in Jiangsu were concentrated in advanced manufacturing, healthcare, and energy/mining, which together accounted for 71.8% of the total [8] - Notable companies include Jiangsu's largest IPO, United Power, valued at approximately 66 billion yuan, and Qiangyi Co., valued at 48 billion yuan [10] Regional Insights - Suzhou emerged as the leading city in Jiangsu with 19 IPOs, representing 41.3% of the province's total [11] - Jiangsu's IPOs were distributed across 11 cities, with significant contributions from cities like Wuxi and Changzhou [11][13] Long-term Trends - Over the past five years, Jiangsu has facilitated the listing of 265 companies, establishing itself as a key player in the capital market [18][21] - The province's investment events have increased significantly, from 272 in 2013 to nearly 2000 in recent years, indicating a robust investment environment [20] Role of Venture Capital - A high percentage of IPO companies in Jiangsu (87%) had received VC/PE investment, surpassing the national average of 57.8% [19] - Local investment institutions have been active, with five of the top ten direct investment institutions in China based in Jiangsu [25] Future Outlook - Jiangsu has launched several large-scale investment funds, including a 50 billion yuan mother fund, which is expected to sustain investment activity in the coming years [26] - The province's entrepreneurial landscape is characterized by a high number of engineers as founders, focusing on practical industrial opportunities [34][36]

Group 1 - The core viewpoint of the news is that Hanbang Technology experienced a slight decline in stock price and notable changes in financing activities on January 19, with a net financing outflow of 292.90 thousand yuan [1] - On January 19, Hanbang Technology's financing buy amounted to 152.72 thousand yuan, while the financing balance reached 6,291.74 thousand yuan, accounting for 8.53% of the circulating market value [1] - The company specializes in providing separation and purification equipment, consumables, application technology services, and related technical solutions for the pharmaceutical and life sciences sectors, with revenue composition being 70.99% from small molecule drug separation and purification equipment, 22.94% from large molecule drug separation and purification equipment, and 6.07% from others [1] Group 2 - As of September 30, Hanbang Technology had 8,687 shareholders, a decrease of 7.31% from the previous period, while the average circulating shares per person increased by 7.89% [2] - For the period from January to September 2025, Hanbang Technology reported operating revenue of 506 million yuan, a year-on-year increase of 4.61%, but the net profit attributable to shareholders decreased by 17.27% to 37.02 million yuan [2] - Since its A-share listing, Hanbang Technology has distributed a total of 8.80 million yuan in dividends [2]

证券代码：688755 证券简称：汉邦科技 公告编号：2026-002 江苏汉邦科技股份有限公司 关于开立募集资金现金管理产品专用结算账户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 江苏汉邦科技股份有限公司（以下简称"公司"）于 2025 年 6 月 10 日召开 第一届董事会第十九次会议和第一届监事会第十一次会议，审议通过了《关于使 用部分暂时闲置募集资金进行现金管理的议案》，同意公司（含实施募投项目的 子公司，下同）在确保不影响公司正常经营、不影响募集资金投资计划正常进行 及确保募集资金安全的前提下，使用最高不超过人民币 39,800.00 万元（单日最 高余额，含本数）的暂时闲置募集资金进行现金管理，用于购买安全性高、流动 性好的保本型产品（包括但不限于保本型理财产品、定期存款、通知存款、大额 存单、协定存款、结构性存款、收益凭证等）。在上述额度范围内，资金可以滚 动使用，使用期限自公司董事会审议通过之日起 12 个月内有效。具体内容详见公 司于上海证券交易所网站（www.sse.com.cn）披露的《关 ...

证券代码：688755 证券简称：汉邦科技 公告编号：2026-001 江苏汉邦科技股份有限公司 关于注销募集资金现金管理产品专用结算账户的公告 二、本次募集资金现金管理专用结算账户的注销情况 截至本公告披露日，公司在上述募集资金现金管理产品专用结算账户内的理 财产品已全部到期，现金管理专用结算账户内资金已全部赎回且在此账户无下一 步购买计划，根据《上市公司监管指引第 2 号——上市公司募集资金管理和使用 的监管要求》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运 作》等相关规定，公司于近日办理完毕上述募集资金现金管理专用结算账户的注 销手续。具体账户信息如下： | 序号 | 账户名称 | 开户机构 | 资金账号 | 账户状态 | | --- | --- | --- | --- | --- | | 1 | 江苏汉邦科技股 | 兴业银行股份有限公司 | 402310100200343110 | 本次注销 | | | 份有限公司 | 淮安分行 | | | | 2 | 江苏汉邦科技股 | 中国建设银行股份有限公 | 32001725336049505688*219 | 本次注销 | | | 份有限公 ...

Summary of Key Points Core Viewpoint - On January 9, a total of 3,760 A-shares received financing funds for purchase, with 777 stocks having purchase amounts exceeding 100 million yuan [1] Group 1: Financing Purchase Amounts - The top three stocks by financing purchase amount were Zhongji Xuchuang, Jin Feng Technology, and Xinwei Communication, with amounts of 3.517 billion yuan, 2.654 billion yuan, and 2.516 billion yuan respectively [1] - Six stocks had financing purchase amounts accounting for over 30% of the total transaction amount for the day [1] Group 2: Financing Purchase Proportions - The stocks with the highest financing purchase amount as a percentage of total transaction amount were Hanbang Technology, Jiyuan Group, and Modern Investment, with proportions of 42.51%, 33.43%, and 32.75% respectively [1] Group 3: Net Financing Purchases - A total of 68 stocks had net financing purchases exceeding 100 million yuan [1] - The top three stocks by net financing purchase amounts were China Ping An, Jin Feng Technology, and Zhongji Xuchuang, with net purchases of 1.137 billion yuan, 949 million yuan, and 541 million yuan respectively [1]

证券日报网讯 1月7日，汉邦科技在互动平台回答投资者提问时表示，公司工业制备液相色谱系统及相 关纯化设备，可广泛应用于生物医药（包括胰岛素、抗体、疫苗、抗生素等）的分离纯化环节。公司始 终密切关注下游市场需求变化，并积极把握市场机遇，具体订单情况请详见公司披露的定期报告。 ...

Core Insights - In 2025, a total of 116 new companies are expected to be listed on the Shanghai Stock Exchange, Shenzhen Stock Exchange, and Beijing Stock Exchange, raising a total of 131.77 billion yuan [1] - The Sci-Tech Innovation Board (科创板) will see 19 companies listed, collectively raising 38.06 billion yuan [1] Listing Standards - 11 companies, including Qiangyi Co., Jianxin Superconducting, and Youxun Co., opted for the first set of listing standards, which require a market value of at least 1 billion yuan and positive net profits over the last two years totaling at least 50 million yuan, or a market value of at least 1 billion yuan with positive net profit and revenue of at least 100 million yuan in the last year [1] - Moer Thread chose a higher standard requiring a market value of at least 1.5 billion yuan, with revenue of at least 200 million yuan in the last year and R&D investment accounting for at least 15% of total revenue over the last three years [1] - Companies like Muxi Co., Bai'ao Saitu, and Xian Yicai selected a standard requiring a market value of at least 3 billion yuan and revenue of at least 300 million yuan in the last year [2] Specific Company Listings - Qiangyi Co. raised 2.756 billion yuan, with underwriting fees of 192.05 million yuan, and is categorized under the first standard [3] - Jianxin Superconducting raised 779 million yuan, with underwriting fees of 59.52 million yuan, also under the first standard [3] - Muxi Co. raised 4.197 billion yuan, with underwriting fees of 267.23 million yuan, categorized under the fourth standard [3] - Angrui Micro raised 2.067 billion yuan, with underwriting fees of 114.87 million yuan, meeting the sixth standard [3] - He Yuan Bio and Biobetter both selected the fifth standard, requiring a market value of at least 4 billion yuan and significant regulatory approval for their products [2][3]

Group 1 - The article highlights the behavior of margin traders, indicating that investors are looking for investment opportunities through their activities [1] - On December 30, a total of 3,757 stocks received margin buying funds, with the top three stocks being Sanhua Intelligent Controls at 2.296 billion, Zhongji Xuchuang at 2.293 billion, and Xinyi Sheng at 1.910 billion [1] - Among the stocks with significant margin buying, 10 stocks had a margin buying amount that exceeded 30% of their total trading volume [1] Group 2 - The top stocks by margin buying amount and their respective trading volumes and percentages are detailed, with notable mentions including Qingtang City at 24.35 million and Daya Shengxiang at 12.86 million [2] - The data shows that the margin buying percentage for several stocks is high, with Qingtang City at 43.09%, Daya Shengxiang at 40.80%, and Guangming Meat Industry at 35.66% [1][2] - The article provides a comprehensive table listing various stocks, their margin buying amounts, total trading amounts, margin buying percentages, and daily price changes [1][2]